Survey of hematological aspects of Gaucher disease

Ari Zimran; Gheona Altarescu; Bernard Rudensky; Aya Abrahamov; Deborah Elstein

doi:10.1080/10245330500067181

Survey of hematological aspects of Gaucher disease

Ari Zimran
, Gheona Altarescu
, Bernard Rudensky
, Aya Abrahamov
, Deborah Elstein^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

75 Scopus citations

Abstract

Hematologists have classically been the treating physicians of patients with Gaucher disease, and today, despite both specific and symptomatic therapeutic advances, they remain at the forefront of specialists to whom patients with Gaucher disease present. It is therefore appropriate to review that has changed and what has remained the same in hematological signs and symptoms of the disease in the decade and a half since therapy has become available.

Original language	English
Pages (from-to)	151-156
Number of pages	6
Journal	Hematology
Volume	10
Issue number	2
DOIs	https://doi.org/10.1080/10245330500067181
State	Published - Apr 2005
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 7 Affordable and Clean Energy

Keywords

Anemia
Bleeding
Enzyme replacement therapy
Gaucher disease
Thrombocytopenia

Access to Document

10.1080/10245330500067181

Cite this

@article{c1009078a37a4666b2e39620391bfe4b,

title = "Survey of hematological aspects of Gaucher disease",

abstract = "Hematologists have classically been the treating physicians of patients with Gaucher disease, and today, despite both specific and symptomatic therapeutic advances, they remain at the forefront of specialists to whom patients with Gaucher disease present. It is therefore appropriate to review that has changed and what has remained the same in hematological signs and symptoms of the disease in the decade and a half since therapy has become available.",

keywords = "Anemia, Bleeding, Enzyme replacement therapy, Gaucher disease, Thrombocytopenia",

author = "Ari Zimran and Gheona Altarescu and Bernard Rudensky and Aya Abrahamov and Deborah Elstein",

year = "2005",

month = apr,

doi = "10.1080/10245330500067181",

language = "אנגלית",

volume = "10",

pages = "151--156",

journal = "Hematology",

issn = "1024-5332",

publisher = "Taylor and Francis Ltd.",

number = "2",

}

TY - JOUR

T1 - Survey of hematological aspects of Gaucher disease

AU - Zimran, Ari

AU - Altarescu, Gheona

AU - Rudensky, Bernard

AU - Abrahamov, Aya

AU - Elstein, Deborah

PY - 2005/4

Y1 - 2005/4

N2 - Hematologists have classically been the treating physicians of patients with Gaucher disease, and today, despite both specific and symptomatic therapeutic advances, they remain at the forefront of specialists to whom patients with Gaucher disease present. It is therefore appropriate to review that has changed and what has remained the same in hematological signs and symptoms of the disease in the decade and a half since therapy has become available.

AB - Hematologists have classically been the treating physicians of patients with Gaucher disease, and today, despite both specific and symptomatic therapeutic advances, they remain at the forefront of specialists to whom patients with Gaucher disease present. It is therefore appropriate to review that has changed and what has remained the same in hematological signs and symptoms of the disease in the decade and a half since therapy has become available.

KW - Anemia

KW - Bleeding

KW - Enzyme replacement therapy

KW - Gaucher disease

KW - Thrombocytopenia

UR - https://www.scopus.com/pages/publications/24644466574

U2 - 10.1080/10245330500067181

DO - 10.1080/10245330500067181

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 16019462

AN - SCOPUS:24644466574

SN - 1024-5332

VL - 10

SP - 151

EP - 156

JO - Hematology

JF - Hematology

IS - 2

ER -

Survey of hematological aspects of Gaucher disease

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this